NewsRegulations & Policy

Govt unveils e-Office portal of PCIM&H for pharmacopoeia monographs

The online portal will promote the hassle-free reach of pharmacopoeia monographs among stakeholders across the world

Union Minister of Ayush and Ports, Shipping and Waterways Sarbananda Sonowal visited Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H), Ghaziabad and inaugurated e-Office portal of PCIM&H and an online portal. The online portal is for selling the soft copies of pharmacopoeial monographs. 

The Minister inspected the laboratories viz. Pharmacognosy, Phytochemistry, Microbiology, herbal garden and raw drug repository of ASU&H drugs.

Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H) under the Ministry of Ayush is actively engaged in the Standardization and Quality Control of Ayurveda, Siddha, Unani and Homoeopathic (ASU&H) drugs and is publishing the standards in the form of Pharmacopoeias. 

Sonowal mentioned that PCIM&H is doing remarkable work to maintain the quality of ASU&H drugs. He expressed his pleasure that PCIM&H is having a team of learned scientists and technical staff. He further mentioned that Yoga has been accepted by all globally and practice of yoga is helpful to manage lifestyle diseases and also helps to prevent diseases. 

Dr Kousthubha Upadhyaya, Adviser (Ayurveda) Ministry of Ayush and Director, PCIM&H Dr Raman Mohan Singh were also present during his visit to PCIM&H. 

Sonowal also inaugurated the e-Office portal of PCIM&H and the online portal. This online portal is for selling the softcopies of pharmacopoeial monographs”. The online portal will promote the hassle-free reach of pharmacopoeia monographs among stakeholders across the world. 

Minister also released the Monthly Newsletters published by PCIM&H. Newsletter of PCIM&H showcases the activities of PCIM&H and is also a way to update the stakeholders about the new developments in the field of Quality Control and Standardization of ASAU&H drugs.

PIB

Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.

Tags

Related Articles

Back to top button
Close
Close